In this study, we reported new dual P-gp/hCAXII inhibitors basedon the evidence that in several MDR cancer cells P-gp is colocalizedto hCA XII and that the hCA XII catalytic activity modulates the P-gpefflux activity. The gene discussed is PGP; the disease is cancer.